Last quarter (Q4 2023), Aurinia Pharmaceuticals's total revenue was $45.09M, an increase of 58.59% from the same quarter last year. In Q4, Aurinia Pharmaceuticals's net income was $-26.88M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 175.51M	$ 175.51M	$ 134.03M	$ 45.60M	$ 50.12M	$ 318.00K
Cost of Revenue	$ 14.15M	$ 14.15M	$ 5.66M	$ 1.09M	$ 0.00	$ 52.87M
Gross Profit	$ 161.37M	$ 161.37M	$ 128.37M	$ 44.51M	$ 50.12M	$ -52.55M
Operating Expense	$ 244.68M	$ 244.68M	$ 241.36M	$ 225.25M	$ 154.41M	$ 76.34M
Operating Income	$ -83.31M	$ -83.31M	$ -112.99M	$ -180.74M	$ -104.29M	$ -76.02M
Net Non Operating Interest Income Expense	$ 14.22M	$ 14.22M	$ 5.12M	$ -529.00K	$ 1.52M	$ 2.70M
Other Income Expense	$ 8.38M	$ 8.38M	$ -1.52M	-	$ -6.81M	$ -14.92M
Pretax Income	$ -77.47M	$ -77.47M	$ -106.35M	$ -180.21M	$ -102.77M	$ -88.24M
Tax Provision	$ 551.00K	$ 551.00K	$ 1.83M	$ 760.00K	$ -94.00K	$ 144.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -78.02M	$ -78.02M	$ -108.18M	$ -180.97M	$ -102.68M	$ -88.39M
Basic EPS	$ -0.54	$ -0.54	$ -0.76	-	$ -0.87	$ -1.33
Diluted EPS	$ -0.54	$ -0.54	$ -0.76	-	$ -0.87	$ -1.33
Basic Average Shares	$ 572.94M	$ 143.24M	$ 141.91M	-	$ 118.47M	$ 93.02M
Diluted Average Shares	$ 572.94M	$ 143.24M	$ 141.91M	-	$ 118.47M	$ 93.02M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	$ 2.36M
Total Expenses	$ 190.69M	$ 258.82M	-	$ -226.34M	$ 154.41M	$ 76.34M
Net Income From Continuing And Discontinued Operation	$ -78.02M	$ -78.02M	$ -108.18M	$ -180.97M	$ -102.68M	$ -88.39M
Normalized Income	$ -64.29M	$ -56.94M	$ -78.17M	$ -132.45M	$ -102.68M	$ -88.39M
Interest Expense	-	-	-	-	-	$ 39.00K
EBIT	$ -74.69M	$ -74.69M	$ -106.35M	$ -180.21M	$ -104.29M	$ -76.02M
EBITDA	$ -77.21M	$ -75.19M	$ -106.35M	$ -177.44M	$ -102.92M	$ -74.85M

Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing